Clinical trial · Interventional
The Effect of Home-Based Walking Program on Peripheral Neuropathy, Fatigue and Quality of Life
The Effect of Home-Based Walking Program on Peripheral Neuropathy, Fatigue and Quality of Life in Patients Receiving Taxane and Platinum-Based Chemotherapy
NCT06012253CI-TRIAL-00091127completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The study aims to evaluate the effect of home-based walking program on peripheral neuropathy, fatigue and quality of life in patients receiving taxane and platinum-based chemotherapy.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Chemotherapeutic Toxicity | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Home Based Walking Program | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Home Based Walking Program
- description
- Effect of home-based walking program on peripheral neuropathy, fatigue and quality of life
- interventionNames
- Other: Home Based Walking Program
- type
- NO_INTERVENTION
- label
- Control group
- description
- The control group will be given the "Ministry of Health Physical Activity Guidelines".Routine care.
Primary outcomes (5)
- measure
- International Physical Activity Questionnaire (IPAQ- Short Form)
- timeFrame
- Baseline and 8th week
- description
- It is used to evaluate physical activity. The form includes walking, moderate and vigorous activity, sitting categories. The total score includes the sum of time (minutes) and frequency (days).
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
İnclusion Criteria * 18 Years and older (Adult, Older Adult ) * Turkish speaking-understanding ability and literate. * Orientation (person, place, time) * Receiving taxane and platinum-based chemotherapy treatment (monotherapy or combined). * Receiving chemotherapy treatment for the first time. * The primary medical diagnosis is cancer (breast cancer, colorectal cancers and other cancers). * Not having health problems that prevent walking. * Agreeing to participate in the research. Exclusion Criteria * Being bone and brain metastases * Being peripheral neuropathy due to reasons other than chemotherapy (such as chronic disease, diabetes mellitus, nutritional disorders) * Skin sensitivity on the hands and feet * Having cardiovascular, pulmonary, musculoskeletal, or psychological disorders that limit exercise or mobility * Being in another supportive program * Being in the very active category according to the "International Physical Activity Scale (IPAQ- Short Form)" * Being a severity of more than 4 points according to the "Modified Borg Scale (MBS)" * Being a score of 2 and above according to the "ECOG Performance Scale"
References
Publications (0)
Data not yet available
No reference posted for this study.